The agreement will see Aesthetic Solutions distribute Soliton’s rapid acoustic pulse (RAP) device and advanced design cartridges during a U.S. commercial launch targeted for the first half of 2021.
Soliton’s RAP device uses rapid pulses of acoustic shockwaves as an accessory to lasers in the removal of unwanted tattoos, according to a news release.
Aesthetic Solutions is set to focus on and target placement of the RAP device in physician practices that treat high volumes of tattoo removal and cellulite reduction, once the device garners FDA clearance. Under the agreement, Aesthetic Solutions will sell and service the RAP devices until Soliton’s direct sales force is fully established for the 2021 rollout.
“We are excited to have set in place a plan for the strategic distribution of our RAP device for our initial commercial launch,” Soliton founder, president & CEO Dr. Christopher Capelli said in the release. “Aesthetic Solutions has an exceptional reputation in the industry and we believe will generate positive results for Soliton among dermatologists, particularly key opinion leaders with strong relationships with their patients. Our relationship with Aesthetic Solutions represents a key step forward in accomplishing a successful commercial launch and we welcome their team as our sales and distribution partner.”
“We are thrilled to partner with Soliton for the sales and distribution of its unique multi-indication aesthetic device,” added Aesthetic Solutions president Tim Howder. “With 30 years of experience in aesthetic medical device rentals and distribution, we are excited to apply our unique skill sets in a program of strategic device distribution and service. Our highly trained sales and service staff teams are eager and ready to partner with Soliton to ensure success in the launch of this exciting multi-use device.
“We are well-equipped to support the company’s upcoming launch and we look forward to a successful relationship.”